|Bid||16.50 x 1200|
|Ask||17.31 x 1300|
|Day's Range||16.32 - 17.04|
|52 Week Range||14.48 - 31.54|
|Beta (5Y Monthly)||1.17|
|PE Ratio (TTM)||N/A|
|Earnings Date||Nov 05, 2020|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||31.33|
Theravance Biopharma, Inc. (NASDAQ: TBPH), a diversified biopharmaceutical company primarily focused on the discovery, development and commercialization of organ-selective medicines, will webcast a presentation as follows:
Theravance (TBPH) falls more than 13% as it reports wider-than-expected loss for the third quarter of 2020. Revenues meet estimates.
Last week, you might have seen that Theravance Biopharma, Inc. (NASDAQ:TBPH) released its quarterly result to the...